Establishment and Analysis of an Individualized EMT-Related Gene Signature for the Prognosis of Breast Cancer in Female Patients

Figure 9

(a–c) DCA analysis predicting 1-, 3-, and 5-year overall survival (OS) in the training set; (d–f) DCA analysis predicting 1-, 3-, and 5-year; overall survival (OS) in the test set; (g–i) DCA analysis predicting 1-, 3-, and 5-year overall survival (OS) in the overall internal validation set.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)